期刊文献+

祛瘀消异汤治疗子宫腺肌病的临床疗效分析 被引量:2

The Curative Effect of Stasis Elimination Decoction in the Treatment of Uterine Adenomyosis
下载PDF
导出
摘要 目的观察祛瘀消异汤治疗子宫腺肌病的效果。方法选取2010—2012年来本院就诊的587例子宫腺肌病患者。患者自愿选择服药种类,分单纯口服避孕药组、口服避孕药加祛瘀消异汤组、单纯口服祛瘀消异汤组。坚持服药半年,接受跟踪随访,比较3组疗效。结果资料完整者368例,单纯口服避孕药组与口服避孕药加祛瘀消异汤治疗组间疗效比较,差异有统计学意义(P<0.05);单纯口服避孕药组与单纯口服祛瘀消异汤组间疗效比较,差异有统计学意义(P<0.05)。结论口服祛瘀消异汤治疗子宫腺肌病疗效显著,不良反应少,复发率低。 Objective To observe the effect of the stasis elimination decoction in the treatment of uterine adenomyosis. Methods 587 patients with uterine adenomyosis in our hospital from 2010 to 2012,which were divided into oral contraceptives group,oral contraceptives and stasis elimination decoction group,stasis elimination decoction group. Patients medication adherence for half a year,accepted the follow up. Curative effect of three groups were compared. Results 368 patients complete data,curative effect between oral contraceptives group and oral contraceptives and stasis elimination decoction group showed significant differences( P〈0. 05); Curative effect between oral contraceptives group and stasis elimination decoction group showed significant differences( P〈0. 05). Conclusion The curative effect of stasis elimination decoction in the treatment of uterine adenomyosis is remarkable,has less adverse reaction,low recurrence rate.
出处 《临床合理用药杂志》 2014年第21期121-123,共3页 Chinese Journal of Clinical Rational Drug Use
关键词 子宫腺肌病 避孕药 口服 祛瘀消异汤 治疗结果 Uterine adenomyosis Contraceptives oral Stasis elimination decoction Treatment outcome
  • 相关文献

参考文献3

二级参考文献10

  • 1周应芳,麦永嫣,郑淑蓉.子宫腺肌症的发病原因和诊治研究进展[J].中华妇产科杂志,1995,30(8):502-505. 被引量:131
  • 2康佳丽,黄晓晖,王小霞,夏薇.子宫腺肌病的免疫学研究进展[J].广州医学院学报,2006,34(1):72-74. 被引量:2
  • 3[3]Komai K,Nishida T.Tumor marker in ovarian cancer.Gan To Kagakn Ryoho,2002,29(3):481
  • 4[4]Barbieri RL.CA125 in patients with endometriosis.Fertil Steril,1986,45(6):767
  • 5[5]Krasnicki D.Serum and peritoneal fluid CA125 concentration in women with endometriosis.Ginekol Pol,2001,72(12A):1365
  • 6[6]Kauppila A,Telimaa S,Ronnberg L,et al.Placebo-controlled study on serum concentrations of CA-125 before and after treatment of endometriosis with danazol or high-dose medroxyprogesterone acetate alone or after surgery.Fertil Steril,1988,49(1):37
  • 7中华人民共和国卫生部.中药(新药)临床研究指导原则[S].1995,171.
  • 8IshiiK,TakakuwaK,MitsuiT,et al.Studies on the human leukocyte antigenDR in patients with endometriosis genotyping of HLADRB1 alleles[J].Hum Reprod,2002,17(3):560.
  • 9Krasnicki D.Serum and peritoneal fluid CA125 concentration.in women with endometriosis[J].Ginekol Pol,2001,72(12A):1365.
  • 10McBean JH,Brumsted JR.In vitro CA125 seretion by endometrium from women with advanced endometriosis[J].Fertil Steril,1993,59(1):89.

共引文献61

同被引文献6

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部